[go: up one dir, main page]

DK1245232T3 - Oralt fast præparat - Google Patents

Oralt fast præparat

Info

Publication number
DK1245232T3
DK1245232T3 DK00974881T DK00974881T DK1245232T3 DK 1245232 T3 DK1245232 T3 DK 1245232T3 DK 00974881 T DK00974881 T DK 00974881T DK 00974881 T DK00974881 T DK 00974881T DK 1245232 T3 DK1245232 T3 DK 1245232T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical
krp
quantitatively
oral solid
additives
Prior art date
Application number
DK00974881T
Other languages
Danish (da)
English (en)
Inventor
Toshinori Ohyama
Masahiko Ohishi
Yasuhiro Yamamoto
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Application granted granted Critical
Publication of DK1245232T3 publication Critical patent/DK1245232T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00974881T 1999-11-11 2000-11-10 Oralt fast præparat DK1245232T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32058599 1999-11-11

Publications (1)

Publication Number Publication Date
DK1245232T3 true DK1245232T3 (da) 2006-03-06

Family

ID=18123071

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00974881T DK1245232T3 (da) 1999-11-11 2000-11-10 Oralt fast præparat

Country Status (12)

Country Link
US (1) US7351429B1 (fr)
EP (1) EP1245232B1 (fr)
JP (1) JP4610834B2 (fr)
AT (1) ATE316375T1 (fr)
AU (1) AU1304501A (fr)
CA (1) CA2390933C (fr)
CY (1) CY1104982T1 (fr)
DE (1) DE60025750T2 (fr)
DK (1) DK1245232T3 (fr)
ES (1) ES2254246T3 (fr)
TW (1) TWI221412B (fr)
WO (1) WO2001034147A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005011683A1 (fr) * 2003-08-04 2005-02-10 Kyorin Pharmaceutical Co., Ltd. Preparation pour absorption transdermique
US20070092566A1 (en) * 2003-08-04 2007-04-26 Ryouichi Hoshino Oral sustained-release tablet
AU2004290520A1 (en) * 2003-11-18 2005-06-02 Boehringer Ingelheim International Gmbh Solid pharmaceutical preparation form
CA2596548A1 (fr) * 2005-01-31 2006-08-03 Kyorin Pharmaceutical Co., Ltd. Preparation multidose a liberation prolongee pour administration par voie orale et procede de production de celle-ci
WO2006082888A1 (fr) 2005-02-03 2006-08-10 Kyorin Pharmaceutical Co., Ltd. Preparation pour absorption percutanee
CN101983054B (zh) * 2008-01-31 2013-08-14 杏林制药株式会社 含有咪达那新的口腔内迅速崩解性片剂
JP4656672B2 (ja) * 2008-01-31 2011-03-23 杏林製薬株式会社 イミダフェナシンを有効成分とする口腔内速崩錠の製造方法
JP5452051B2 (ja) * 2009-03-27 2014-03-26 杏林製薬株式会社 イミダフェナシン含有口腔内崩壊錠
JP5452050B2 (ja) * 2009-03-27 2014-03-26 杏林製薬株式会社 イミダフェナシンを含有する口腔内崩壊錠
JP5713544B2 (ja) * 2009-07-30 2015-05-07 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
JP5844573B2 (ja) * 2011-08-10 2016-01-20 共和薬品工業株式会社 ピタバスタチンを含有する錠剤
JP5757493B1 (ja) * 2014-09-24 2015-07-29 富田製薬株式会社 経口型鉄分補給用固形組成物及びその製造方法
JP6127295B2 (ja) * 2015-03-10 2017-05-17 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
CA2980097C (fr) * 2015-03-19 2019-10-29 Daiichi Sankyo Company, Limited Colorant contenant une preparation solide
EP3272345B1 (fr) 2015-03-19 2019-10-16 Daiichi Sankyo Company, Limited Préparation solide contenant un agent antioxydant
JP6072884B2 (ja) * 2015-11-19 2017-02-01 共和薬品工業株式会社 ピタバスタチンを含有する製剤
KR102699271B1 (ko) 2015-12-25 2024-08-27 교린 세이야꾸 가부시키 가이샤 바소프레신 유사 작용 증강제
JP6212588B2 (ja) * 2016-03-24 2017-10-11 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
US10966928B2 (en) * 2016-03-25 2021-04-06 Universiteit Gent Oral dosage form
ES2883352T3 (es) * 2016-03-25 2021-12-07 Univ Gent Forma de dosificación oral
JP6303037B2 (ja) * 2017-02-14 2018-03-28 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
JP6303038B2 (ja) * 2017-02-14 2018-03-28 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
JP6509934B2 (ja) * 2017-03-30 2019-05-08 杏林製薬株式会社 直打法によるイミダフェナシンを含有する錠剤の製造方法
JP6303045B1 (ja) * 2017-03-30 2018-03-28 杏林製薬株式会社 攪拌造粒法を用いたイミダフェナシンを含有する製剤の製造方法
JP6303044B1 (ja) * 2017-03-30 2018-03-28 杏林製薬株式会社 押出し造粒法を用いたイミダフェナシンを含有する製剤の製造方法
JP6423034B2 (ja) * 2017-03-30 2018-11-14 杏林製薬株式会社 イミダフェナシン含有錠剤
JP6423033B2 (ja) * 2017-03-30 2018-11-14 杏林製薬株式会社 製造工程分解物の少ないイミダフェナシンを含有する造粒物
JP6435362B2 (ja) * 2017-03-30 2018-12-05 杏林製薬株式会社 保存安定性に優れたイミダフェナシンを含有する製剤
JP6423035B2 (ja) * 2017-03-30 2018-11-14 杏林製薬株式会社 イミダフェナシン含有造粒物のコーティング顆粒
JP6435363B2 (ja) * 2017-03-30 2018-12-05 杏林製薬株式会社 湿式造粒法によるイミダフェナシンを含有する造粒物の製造方法
JP7365157B2 (ja) * 2018-07-17 2023-10-19 沢井製薬株式会社 イミダフェナシン含有錠剤の製造方法
KR102849723B1 (ko) 2018-07-30 2025-08-22 다이이찌 산쿄 가부시키가이샤 안정화제를 함유하는 의약품의 고형 제제
JP2018203789A (ja) * 2018-10-09 2018-12-27 杏林製薬株式会社 製造工程分解物の少ないイミダフェナシンを含有する造粒物
JP2019019148A (ja) * 2018-11-12 2019-02-07 杏林製薬株式会社 保存安定性に優れたイミダフェナシンを含有する製剤
JP2019104761A (ja) * 2019-04-03 2019-06-27 杏林製薬株式会社 直打法によるイミダフェナシンを含有する錠剤の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58206533A (ja) * 1982-05-27 1983-12-01 Teijin Ltd 活性型ビタミンｄ↓３誘導体組成物及びそれを活性成分とする薬剤
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
JP3294961B2 (ja) * 1993-12-10 2002-06-24 杏林製薬株式会社 新規イミダゾール誘導体及びその製造法
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
DE69815003T2 (de) * 1997-09-10 2004-04-01 Takeda Chemical Industries, Ltd. Stabilisierte pharmazeutische Zusammensetzung
JP4730985B2 (ja) * 1997-09-10 2011-07-20 武田薬品工業株式会社 安定化された医薬製剤
JP3901832B2 (ja) 1998-03-13 2007-04-04 大日本インキ化学工業株式会社 キノリノン誘導体製剤、及びその製造法

Also Published As

Publication number Publication date
CA2390933A1 (fr) 2001-05-17
WO2001034147A1 (fr) 2001-05-17
EP1245232A1 (fr) 2002-10-02
DE60025750T2 (de) 2006-10-19
DE60025750D1 (de) 2006-04-13
EP1245232B1 (fr) 2006-01-25
ATE316375T1 (de) 2006-02-15
US7351429B1 (en) 2008-04-01
EP1245232A4 (fr) 2004-05-06
CA2390933C (fr) 2009-07-14
ES2254246T3 (es) 2006-06-16
AU1304501A (en) 2001-06-06
JP4610834B2 (ja) 2011-01-12
TWI221412B (en) 2004-10-01
CY1104982T1 (el) 2009-11-04

Similar Documents

Publication Publication Date Title
DK1245232T3 (da) Oralt fast præparat
NO2013002I2 (no) Aklidiniumsalt med et farmaøytisk akseptabelt anion av en mono-eller polyvalent syre, spesielt aklidiniumbromid
DE69206345D1 (de) Arzneimittel zur intranasalen Verabreichung, die Ketorolac R enthalten.
ATE78157T1 (de) Arzneimittel mit langsamer freisetzung.
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
ZA874577B (en) New galenic formulations with programmed release containing antiphlogistics
TR200102226T2 (tr) Formoterol ve bir tiotropium tuzunun kombinasyonları
FI892016A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten, mahdollisesti -substituoitujen 4-(-kinolin-2-yyli-metoksi)-fenyylietikkahappojen ja -esterien valmistamiseksi
DK1161248T3 (da) Farmaceutisk sammensætning indeholdende en nitratkilde og et forsurende middel til behandling af åbne sår og forbrændinger
NO20020516D0 (no) Stabilt farmasöytisk preparat for oralt bruk
SE9902386D0 (sv) New formulation
ITMI913170A1 (it) Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi
DE69521924D1 (de) Pharmazeutische Darreichungsformen mit verzögerter Wirkstoffabgabe enthaltend Alfuzosinhydrochlorid
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
GB9814215D0 (en) Anti-inflammatory pharmaceutical formulations
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
MY100483A (en) Niflumic acid morpholinoethyl ester diniflumate, preparation, use in therapeutics as analgesic and anti- inflammatory
DK0615447T3 (da) Flurbiprofen-holdigt retard-lægemiddel og dets anvendelse
ATE129891T1 (de) Ein ibuprofen enthaltendes retard-arzneimittel und seine verwendung.
GB950065A (en) Pharmaceutical preparations comprising 1:3-benzoxazine-2:4-dione
ES381115A1 (es) Un metodo de preparacion de 1,1'-metilen-bis - (4-(3-cloro-fenil) piperazina).